- FDA committee recommends approval of OraSure's in-home HIV test
- FDA to review Achillion's HCV drug on fast track basis
- FDA unclear on link between Novartis' MS drug Gilenya, patient deaths
- Stiefel's Fabior foam approved for treating acne
- Ohr Pharmaceutical wins fast track designation for wet AMD product candidate
- Private FFS MA plans may be linked with higher costs for beneficiaries, GAO report shows
- Pediatric subspecialty telephone consultations may be cost-saving for Medicaid, research reveals
- Use of mental health services greater in health plans with parity in cost sharing, data find
- Public opinions appear split on health care affordability, satisfaction, survey finds
- In Brief: California Supreme Court
Home :: Hematology/Oncology :: Hematology/Oncology Conferences
30th Annual SABCS
December 12-16, 2007 San Antonio, Texas- Completion axillary dissection may not be required after positive sentinel node biopsy
- Denosumab increases BMD in women with breast cancer receiving AI therapy, findings indicate
- Continuation of tamoxifen beyond standard 5 years reduces breast cancer recurrence, preliminary data show
- Anastrozole appears superior to tamoxifen in reducing risk of recurrence in patients with early breast cancer, data show
- Docetaxel plus cyclophosphamide improves overall survival better than standard chemotherapy in women with breast cancer, data show
